CLNN logo

CLNNClene Inc

$5.45
$0.37
(6.36%)
Today
Closed $5.45
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 14
Mkt Cap$69.64M
Vol114,659.00
News
all
press releases
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Clene (CLNN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
News Placeholder
More News
News Placeholder
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Clene Inc. (CLNN) have performed compared to their sector so far this year.
Zacks
News Placeholder
CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’
Shares of the company rose 8% during regular trading hours but fell after hours following the analyst note.
Stocktwits
News Placeholder
Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates
Clene (CLNN) delivered earnings and revenue surprises of +38.00% and -62.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +15.39% and +0.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Clene (NASDAQ:CLNN) Major Shareholder Sells $34,827.95 in Stock
Clene Inc. (NASDAQ:CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 5,795 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $6.01, for a total value of $34,827.95. Following the sale, the insider directly owned 271,774 shares in the...
MarketBeat
News Placeholder
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 72,884 Shares
Clene Inc. (NASDAQ:CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 72,884 shares of Clene stock in a transaction that occurred on Monday, May 4th. The stock was sold at an average...
MarketBeat
News Placeholder
Promising Nanotechnology Stocks To Watch Today - May 5th
Onto Innovation, Clene, NVE, and Nano Dimension are the seven Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies whose...
MarketBeat
News Placeholder
Nanotechnology Stocks To Watch Today - May 4th
Onto Innovation, Clene, NVE, and Nano Dimension are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies whose core activities involve developing, manufacturing, or commercializing products and processes that man...
MarketBeat
News Placeholder
Clene's (CLNN) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $31.00 price target on shares of Clene in a research note on Monday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.